Stay informed on the latest developments in life sciences research, healthcare policy, and innovative medicines.
For media inquiries, please contact us at media@imc-mnc.ca.
Ottawa, November 20, 2025 – Innovative Medicines Canada (IMC) and Roche Canada are proud to announce the creation of the […]
Ottawa, November 19, 2025 – Innovative Medicines Canada (IMC) is pleased to announce the appointment of Gaby Bourbara, President of […]
Toronto, October 7, 2025 – Innovative Medicines Canada (IMC) applauds the Government of Ontario for its pioneering announcement of the […]
Ottawa, March 18, 2026 – Canada must strengthen its approach to pharmaceutical innovation in a rapidly evolving global environment. Today’s […]
Ottawa, December 4, 2025 — Innovative Medicines Canada (IMC) congratulates the Government of Québec on the launch of the new […]
November 4, 2025 (Ottawa)—Today’s federal budget outlined ambitious plans to reduce government spending while making generational investments to strengthen Canada’s […]
In this episode of From the Burgundy Chairs, Santis Health Senior Advisor Avis Favaro sits down with Dr. Bettina Hamelin, […]
Article by Bettina Hamelin originally published in the Hill Times Health Policy Briefing, page 21, April 22, 2026. By Dr. […]
As originally published in Investment Reports, featured by Newsweek on 10th April 2026 Over the past year, have you seen […]
Have a question or need assistance? We’re here to help.
Innovative Medicines Canada supports initiatives that advance research, raise awareness, and improve access to innovative medicines.
Sign up to our newsletter to get our latest news and updates.
Better health outcomes start with better policy. Explore the issues where IMC is pushing for change on behalf of patients, healthcare professionals and Canada’s life sciences sector.
Timely access to new medicines saves lives, improves health outcomes…
One size does not fit all 97% of Canadians are already eligible for drug coverage. Moving to a one-size-fits-all system […]
The Patented Medicine Prices Review Board (PMPRB) is responsible for ensuring that patented medicines sold in Canada are not excessively […]
One in 12 Canadians, two-thirds of them children, lives with a rare disease. IMC advocates for policies that improve and […]
The value of private drug coverage in Canada More than 27 million Canadians – nearly 70% of the population – […]
Stay informed with timely, relevant content on key issues shaping our industry.
